1115 fiztgerald schuchardt
0 likes137 views
Precision medicine usage has tripled over the last 5 years, with 26% of US hospitals having procured a solution and 22% having gone live. General medical hospitals make up the majority of installations currently. Adoption is highest among multi-hospital nonprofit health systems and larger academic/specialty hospitals. Barriers to further growth include difficulties integrating genomic and other patient data into clinical systems and quantifying return on investment. The document examines trends in precision medicine adoption and provides insights on market leaders, barriers to growth, and signals that could indicate further expansion in the coming years.
1115 fiztgerald schuchardt
- 1. Predictive Analytics World State of Precision Medicine: Where it is Headed and How to Discern the Signal from the Noise
- 2. Healthcare’s Most Comprehensive Market Intelligence Resources & Advisory Solutions Health IT Market Intelligence Health IT Insight & Research Healthcare Organization Benchmarking
- 4. Precision Medicine Usage Precision Medicine usage has tripled in the last 5 years. Today 26% of US Hospitals have procured a Precision Medicine solution and 22% have gone live with installation. The largest volume of installs has been in the General Medical market.
- 5. Precision Medicine Growth General Medical hospitals make up the majority of Precision Medicine Installs because they make up the majority of US hospitals. The growth area for Precision Medicine has been Academic and Specialty Hospitals which represent 18% of the US market. Over half of Academic and Specialty Hospitals have Precision Medicine technologies in place.
- 6. Yes 28.5% Precision Medicine Adoption 2017 vs. 2016 2017 N=100; 2016 N=137 10.3% 10.3% 10.3% 38.5% 30.8% 28.2% 79.5% 4.2% 8.3% 16.7% 16.7% 20.8% 20.8% 29.2% 50.0% 62.5% 0% 20% 40% 60% 80% Unsure Other Epidemiology Neurology Prenatal Screening Endocrinology Nephrology Cardiology Oncology 2017 2016 Similar adoption rates….different mix of focus areas Yes 26.0%
- 7. Health System Influence Health System profit status has a strong influence on adoption of Precision Medicine, and cutting edge technologies in general. Multi-Hospital Not For Profits make up the largest portion of adopters and the largest market segment. Precision Medicine is currently disease state specific with a difficult to quantify return on investment. 1,000 Installed 1,000 Not Installed 2,000 Not Installed 2009 2011 2013 2015 2017 2009 2011 2013 2015 2017 2009 2011 2013 2015 2017 2009 2011 2013 2015 2017 n = 5,490 Data from HIMSS Analytics® LOGIC 2017-10-14. US Hospital Precision Medicine Usage By health system marker segment Health System (Multi): For Profit Health System (Multi): Not For Profit Health System (Single): For Profit Health System (Single): Not For Profit
- 8. Disease Diagnosis, Innovation Leader Primary Drivers 5.1% 12.8% 10.3% 12.8% 15.4% 23.1% 20.5% 4.0% 8.0% 8.0% 12.0% 12.0% 16.0% 20.0% 20.0% 0% 5% 10% 15% 20% 25% Other Enhance patient risk assessment Unsure Conduct drug therapy monitoring Conduct clinical drug trials Become an innovation leader Enhance disease prevention Conduct early disease diagnosis 2017 2016
- 9. Access to Precision Medicine On average, hospitals that have adopted Precision Medicine have twice as many inpatient beds as those that have yet to adopt. Just over a third of inpatient beds are in hospitals with Precision Medicine capabilities, even though those hospitals are less than a quarter of the market.
- 10. Hub & Spoke Deployment? Precision Medicine expansion via Health System networks. Networks limited to distances less than 300 miles.
- 11. IT Approach Hindering ‘Provider to Genome’ Engagement Uses dedicated precision medicine platform AND in-house solutions 36% Uses current in-house solutions only 24% Uses a dedicated precision medicine platform only 16% Unsure 16% Other 8% Integrating the necessary workflows into clinical systems. Integration of the genomic data for use within the clinical dataset. Most Significant Challenge: Data Integration 70%
- 12. 2017 Vendor Market Share 53% of installs are core Health IT vendor 38% of installs are Laboratory vendors 1% of installs are specialty Precision Medicine vendors
- 13. Market Activity
- 14. Inflection Points The strongest indicators of Precision Medicine adoption, are adoption of Laboratory – Outreach Services and Anatomical Pathology. For the top six numerical predictors, the distribution of values by group is overlaid with an inflection point identified via eXtreme Gradiant Boosting.
- 15. Hospitals Likely to Invest in 2018
- 16. Signals from the noise: • Precision Medicine is still in its infancy in terms of adoption • As infrastructure and interoperability mature, the field will expand beyond disease-specific focus • Acquisition of Precision Medicine solution vendors are anticipated to increase over next two years
- 17. Questions?